Profile
Corporate information
Official name
Nutrinia Ltd
Official name
Nutrinia Ltd
Investment activity status
Active investor
Company type
Developer of an oral formulation of insulin for intestinal malabsorption in preterm newborns and SBS in infants.Funding
Funding rounds
Series D USD 30,000,000
USD 30,000,000 (18 Aug 2016)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
TPG Biotechnology Partners LP | United States | Initial investment. Led the round. | |
|
HIG BioHealth Partners | Initial investment. Round participant. | ||
|
|
WuXi Healthcare Ventures | Initial investment. Round participant. | ||
|
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. | United States | Follow-on investment. Round participant. |
|
|
Pontifax | Follow-on investment. Round participant. |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
HIG BioHealth Partners |
Series D | |
|
|
OrbiMed Advisors LLC American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
+1 (212) 739-6400 |
Series D |
|
|
Pontifax |
Series D | |
|
|
TPG Biotechnology Partners LP |
Series D | |
|
|
WuXi Healthcare Ventures |
Series D |